Evidence map›Paper›PMID 31784729›Full record

ArticleNature genetics2019

WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating.

Barbara A Scholz, Noriyuki Sumida, Carolina Diettrich Mallet de Lima, Ilyas Chachoua, Mirco Martino, Ilias Tzelepis, Andrej Nikoshkov, Honglei Zhao, Rashid Mehmood, Emmanouil G Sifakis and 3 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 119 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Re-establishment of TAD boundary organization during DNA replication.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Defective Microhomology-Mediated End-joining in SMARCB1-Deficient Tumors.bioRxiv : the preprint server for biology · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

Barbara A Scholz *Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden.
Noriyuki Sumida *Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden.ORCID http://orcid.org/0000-0001-6121-4553
Carolina Diettrich Mallet de LimaDepartment of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden.
Ilyas ChachouaDepartment of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden.ORCID http://orcid.org/0000-0002-5112-5394
Mirco MartinoDepartment of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden.ORCID http://orcid.org/0000-0002-0954-0359
Ilias TzelepisDepartment of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden.ORCID http://orcid.org/0000-0001-5777-6334
Andrej NikoshkovDepartment of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden.
Honglei ZhaoDepartment of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden.ORCID http://orcid.org/0000-0002-0500-4444
Rashid MehmoodDepartment of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden.
Emmanouil G SifakisDepartment of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden.ORCID http://orcid.org/0000-0001-9919-4471
Deeksha BhartiyaDepartment of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden.
Anita Göndör *Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden. anita.gondor@ki.se.ORCID http://orcid.org/0000-0002-1523-4411
Rolf Ohlsson *Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Bioclinicum, Solna, Sweden. rolf.ohlsson@ki.se.ORCID http://orcid.org/0000-0001-7308-3300
Karolinska University Hospital · SEInformation Technology University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

WNT signaling activates MYC expression in cancer cells. Here we report that this involves an oncogenic super-enhancer-mediated tethering of active MYC alleles to nuclear pores to increase transcript export rates. As the decay of MYC transcripts is more rapid in the nucleus than in the cytoplasm, the oncogenic super-enhancer-facilitated export of nuclear MYC transcripts expedites their escape from the nuclear degradation system in colon cancer cells. The net sum of this process, as supported by computer modeling, is greater cytoplasmic MYC messenger RNA levels in colon cancer cells than in wild type cells. The cancer-cell-specific gating of MYC is regulated by AHCTF1 (also known as ELYS), which connects nucleoporins to the oncogenic super-enhancer via β-catenin. We conclude that WNT signaling collaborates with chromatin architecture to post-transcriptionally dysregulate the expression of a canonical cancer driver.

Indexed as

Enhancer Elements, GeneticGenes, mycbeta CateninColonDNA-Binding ProteinsEpithelial CellsGene Expression Regulation, NeoplasticHCT116 CellsHumansMinor Histocompatibility AntigensNuclear Pore Complex ProteinsProtein TransportProto-Oncogene Proteins c-mycRNA Processing, Post-TranscriptionalTranscription FactorsWnt Signaling PathwayAHCTF1 protein, humanbeta CateninCTNNB1 protein, humanDNA-Binding ProteinsMinor Histocompatibility AntigensNuclear Pore Complex ProteinsNUP133 protein, humanNUP153 protein, humanProto-Oncogene Proteins c-mycTranscription Factors

Identifiers

PMID31784729
OpenAlexW2990225395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.